Nexthera Capital’s Zosano Pharma Corporation ZSAN Stock Holding History

Nexthera Capital’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-22,821	Closed	-$1.69M	–	34
2018 Q4	$1.69M	Sell	22,821 -6,715	-23%	-$850K	0.7%	19
2018 Q3	$4.23M	Buy	29,536 +9,536	+48%	+$1.4M	0.81%	30
2018 Q2	$2.86M	Hold	20,000	–	–	0.44%	34
2018 Q1	$3.53M	Buy	+20,000	New	+$6.69M	0.58%	35
2017 Q4	–	Sell	-537	Closed	-$309K	–	52
2017 Q3	$309K	Sell	537 -61	-10%	-$44.7K	0.08%	34
2017 Q2	$590K	Sell	598 -116	-16%	-$120K	0.26%	36
2017 Q1	$950K	Buy	+714	New	+$862K	0.48%	28

Other funds holding ZSAN

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nexthera Capital's ZSAN Position: Q1 2019 in Review

Nexthera Capital sold out of Zosano Pharma Corporation (ZSAN) in Q1 2019, closing a stake of 22,821 shares — an estimated $1.69M sold.

Nexthera Capital first reported a position in ZSAN in Q1 2017 and held it in 7 quarters. The position peaked at $4.23M in Q3 2018. 19 funds tracked by Wall St. Rank hold ZSAN as of Q1 2019.

Nexthera Capital reported no remaining Zosano Pharma Corporation position as of Q1 2019 after selling out during the quarter.
Nexthera Capital sold 22,821 Zosano Pharma Corporation shares in Q1 2019, an estimated $1.69M.
Nexthera Capital first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 7 quarters.
Nexthera Capital's Zosano Pharma Corporation position peaked at $4.23M in Q3 2018.
19 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2019.

Based on Nexthera Capital's 13F filing for Q1 2019, filed 15 May 2019.